Contineum Therapeutics, Inc. · NASDAQ:CTNM
Ra Capital Management, L.P. reported a 9.90% stake in Contineum Therapeutics, Inc. (Schedule 13G)
Event Jul 18, 2025 · Filed Jul 25, 2025
Ra Capital Management, L.P. reported a 9.90% stake in Contineum Therapeutics, Inc., 2,122,000 shares, as a passive investor on Jul 18, 2025. Filed Jul 25, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 2,122,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 2,122,000 |
| Peter Kolchinsky | 9.90% | 2,122,000 |
| Rajeev Shah | 9.90% | 2,122,000 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 2,122,000 |
Source
Related
- Contineum Therapeutics, Inc.
- Ra Capital Management, L.P.
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026